Corpus Intelligence IC Memo — GREENWOOD REGIONAL REHABILIATION HOS 2026-04-26 09:39 UTC
IC Memo — GREENWOOD REGIONAL REHABILIATION HOS
Investment Committee Memorandum | SC | 42 beds | Grade D | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GREENWOOD REGIONAL REHABILIATION HOS

CCN 423030 | GREENWOOD, SC | 42 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

GREENWOOD REGIONAL REHABILIATION HOS is a 42-bed community hospital in GREENWOOD, SC with $18.2M in net patient revenue and a 0.8% operating margin. The hospital serves a payer mix of 70.4% Medicare, 0.0% Medicaid, and 29.6% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.8% to 8.2% (+736bps).

Net Revenue HCRIS$18.2M
Current EBITDA COMPUTED$146K
Operating Margin COMPUTED0.8%
Occupancy HCRIS60.8%
Revenue / Bed COMPUTED$433K
Net-to-Gross HCRIS71.3%
Distress Probability MLnan%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
41
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of 0.8% places it below the state median. Among 41 size-comparable peers (21-84 beds), the median margin is 2.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (21-84), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GREENWOOD REGIONAL REHABILIATI (Target)SC42$18.2M0.8%
PH PATEWOOD HOSPITALSC64$229.8M38.0%
GEORGETOWN MEMORIAL HOSPITALSC68$168.0M-4.6%
PH GREER MEMORIAL HOSPITALSC66$161.3M31.3%
PH BAPTIST PARKRIDGE HOSPITALSC78$159.8M18.1%
PELHAM MEDICAL CENTERSC48$137.2M17.1%
MUSC HEALTH LANCASTER MEDICAL SC78$128.2M-10.4%
PH HILLCREST HOSPITALSC43$123.6M30.8%
ROPER ST. FRANCIS HOSPITAL-BERSC46$119.0M13.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$382K+210bp18mo
Cost to Collect4.5%2.5%$364K+200bp12mo
Denial Rate Reduction12.0%6.5%$360K+198bp12mo
A/R Days Reduction5200.0%3800.0%$222K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$382K
Cost to Collect
$364K
Denial Rate Reduction
$360K
A/R Days Reduction
$222K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.3M
Current EBITDA$146K
+ RCM Uplift+$1.3M
Pro Forma EBITDA$1.5M
Current Margin0.8%
Pro Forma Margin8.2%
WC Released (1x)$698K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$225K$14.4M63.79x129.6%
Base (11x exit)10.0x11.0x$225K$15.9M70.50x134.2%
Bull Case9.0x11.0x$203K$20.4M100.51x151.4%
Bull (12x exit)9.0x12.0x$203K$22.3M109.94x156.0%
Bear Case11.0x10.0x$248K$7.6M30.65x98.3%
Bear (11x exit)11.0x11.0x$248K$8.4M34.04x102.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 70.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 21-84 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-12.4% / P50=2.0% / P75=16.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.